Creation of a tablet database containing several active ingredients and prediction of their pharmaceutical characteristics based on ensemble artificial neural networks.

A tablet database containing several active ingredients for a standard tablet formulation was created. Tablet tensile strength (TS) and disintegration time (DT) were measured before and after storage for 30 days at 40 degrees C and 75% relative humidity. An ensemble artificial neural network (EANN) was used to predict responses to differences in quantities of excipients and physical-chemical properties of active ingredients in tablets. Most classical neural networks involve a tedious trial and error approach, but EANNs automatically determine basal key parameters, which ensure that an optimal structure is rapidly obtained. We compared the predictive abilities of EANNs in which the following kinds of training algorithms were used: linear, radial basis function, general regression (GR), and multilayer perceptron. The GR EANN predicted pharmaceutical responses such as TS and DT most accurately, as evidenced by high correlation coefficients in a leave-some-out cross-validation procedure. When used in conjunction with a tablet database, the GR EANN is capable of identifying acceptable candidate tablet formulations.

[1]  Andrew Hunter,et al.  Application of neural networks and sensitivity analysis to improved prediction of trauma survival , 2000, Comput. Methods Programs Biomed..

[2]  M. C. Bonferoni,et al.  Characteristics of hydroxypropyl methylcellulose influencing compactibility and prediction of particle and tablet properties by infrared spectroscopy. , 2003, Journal of pharmaceutical sciences.

[3]  M. Gacula 7 – Response Surface Designs and Analysis , 1984 .

[4]  Peter Wolschann,et al.  Comparison between two types of Artificial Neural Networks used for validation of pharmaceutical processes , 2009 .

[5]  Christopher M. Bishop,et al.  Neural networks for pattern recognition , 1995 .

[6]  M. Deaton,et al.  Response Surfaces: Designs and Analyses , 1989 .

[7]  Robert D. Johnson,et al.  Application of Neural Computing in Pharmaceutical Product Development , 1991, Pharmaceutical Research.

[8]  Robert J. Marks,et al.  Neural Smithing: Supervised Learning in Feedforward Artificial Neural Networks , 1999 .

[9]  Kozo Takayama,et al.  Multi-objective simultaneous optimization technique based on an artificial neural network in sustained release formulations , 1997 .

[10]  Christopher T. Rhodes,et al.  Artificial Neural Networks: Implications for Pharmaceutical Sciences , 1995 .

[11]  Lars Kai Hansen,et al.  Neural Network Ensembles , 1990, IEEE Trans. Pattern Anal. Mach. Intell..

[12]  Kozo Takayama,et al.  Multi-objective simultaneous optimization based on artificial neural network in a ketoprofen hydrogel formula containing O-ethylmenthol as a percutaneous absorption enhancer , 1997 .

[13]  T Nagai,et al.  Formula optimization of theophylline controlled-release tablet based on artificial neural networks. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[14]  T Nagai,et al.  Formula optimization based on artificial neural networks in transdermal drug delivery. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[15]  K. Zuurman,et al.  Porosity expansion of tablets as a result of bonding and deformation of particulate solids , 1996 .

[16]  Pierre Bruneau,et al.  Search for Predictive Generic Model of Aqueous Solubility Using Bayesian Neural Nets , 2001, J. Chem. Inf. Comput. Sci..

[17]  Kozo Takayama,et al.  Artificial Neural Network as a Novel Method to Optimize Pharmaceutical Formulations , 2004, Pharmaceutical Research.

[18]  Donald F. Specht,et al.  A general regression neural network , 1991, IEEE Trans. Neural Networks.